Benoit Bailey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Benoit Bailey has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
Anne Letarte
1 shared publicationRené Blais
1 shared publication
Latest Publications
- 1 October 2004
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 44 (4) , 401-406
Status epilepticus after a massive intravenous N-acetylcysteine overdose leading to intracranial hypertension and death
- 1 October 2004
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 44 (4) , 401-406
Status epilepticus after a massive intravenous N-acetylcysteine overdose leading to intracranial hypertension and death
- 1 January 2003
- Published by Taylor & Francis in Journal of Toxicology: Clinical Toxicology
- Vol. 41 (5) , 595-602
Glucagon in β‐Blocker and Calcium Channel Blocker Overdoses: A Systematic Review
Background. Glucagon is usually accepted as part of the standard treatment in the management of patients with β‐blocker and calcium channel blocker overdoses. Methods. A systematic review was done in order to evaluate the evidence supporting glucagon use in β‐blocker and calcium channel blocker overdoses. Studies evaluating glucagon for those uses were identified using the Cochrane Database of Systematic Reviews, the Cochrane Controlled Trials Register, MedLine, ToxLine, and EMBASE searches, as well as reviewing medical toxicology textbooks and references of identified articles. Only controlled studies of human or animal studies were included, the latter only when it was an in vivo model of acute poisoning. The quality of the included studies was assessed. Results. The search found no study in humans but identified 30 in animals. In the five studies of animal models of β‐blocker overdose included, glucagon appeared to consistently increase the heart rate at least transiently but appeared to have n...
- 1 January 2003
- Published by Taylor & Francis in Journal of Toxicology: Clinical Toxicology
- Vol. 41 (5) , 595-602
Glucagon in β‐Blocker and Calcium Channel Blocker Overdoses: A Systematic Review
Background. Glucagon is usually accepted as part of the standard treatment in the management of patients with β‐blocker and calcium channel blocker overdoses. Methods. A systematic review was done in order to evaluate the evidence supporting glucagon use in β‐blocker and calcium channel blocker overdoses. Studies evaluating glucagon for those uses were identified using the Cochrane Database of Systematic Reviews, the Cochrane Controlled Trials Register, MedLine, ToxLine, and EMBASE searches, as well as reviewing medical toxicology textbooks and references of identified articles. Only controlled studies of human or animal studies were included, the latter only when it was an in vivo model of acute poisoning. The quality of the included studies was assessed. Results. The search found no study in humans but identified 30 in animals. In the five studies of animal models of β‐blocker overdose included, glucagon appeared to consistently increase the heart rate at least transiently but appeared to have n...